SRRK
Scholar Rock Holding Corp
NASDAQ: SRRK · HEALTHCARE · BIOTECHNOLOGY
$46.30
-0.92% today
Updated 2026-04-29
Market cap
$5.57B
P/E ratio
—
P/S ratio
13.14x
EPS (TTM)
$-3.29
Dividend yield
—
52W range
$27 – $52
Volume
1.6M
Scholar Rock Holding Corp (SRRK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-15.14M | $-21.74M | $24.57M | $-63.12M | $-60.27M | $-126.79M | $-132.69M | $-145.23M | $-200.95M | $-300.04M |
| Capital expenditures | $794000.00 | $361000.00 | $1.49M | $3.12M | $4.09M | $5.25M | $1.06M | $71000.00 | $98000.00 | $602000.00 |
| Depreciation | $575000.00 | $669000.00 | $807000.00 | $1.30M | $1.49M | $2.63M | $2.99M | $2.84M | $1.94M | — |
| Stock-based comp | $556000.00 | $1.48M | $5.21M | $7.97M | $11.18M | $23.15M | $27.70M | $27.14M | $36.63M | $75.60M |
| Free cash flow | $-15.94M | $-22.10M | $23.08M | $-66.23M | $-64.36M | $-132.04M | $-133.76M | $-145.30M | $-201.05M | $-300.64M |
| Investing cash flow | $-20.32M | $17.66M | $-60.23M | $-62.24M | $-63.50M | $134.31M | $-171.70M | $41.14M | $-76.06M | — |
| Financing cash flow | $1.00M | $50.50M | $94.27M | $48.88M | $247.82M | $44.95M | $194.83M | $102.57M | $353.03M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $58.61M | $-76.47M | $124.05M | $52.48M | $-109.56M | — | — | — |